Research Guide
Mitochondrial peptides are one of the fastest-growing categories in longevity research, but the compounds within it are often lumped together despite acting through very different mechanisms. This guide breaks down MOTS-c and SS-31 specifically, and what actually connects them.
Quick summary
- Mitochondrial peptides are grouped by target, not mechanism — MOTS-c and SS-31 act very differently.
- MOTS-c is a signaling peptide encoded by mitochondrial DNA, studied for metabolic effects via AMPK.
- SS-31 is a synthetic, engineered peptide studied for direct membrane stabilization via cardiolipin binding.
- Both are studied in the context of age-related mitochondrial decline, but through separate research threads.
Why mitochondria became a research focus
Mitochondria are the energy-producing structures inside nearly every cell, and mitochondrial function is well-documented to decline with age. That decline is linked to reduced cellular energy output, increased oxidative stress, and downstream effects across nearly every tissue in the body, which is why mitochondrial-targeted research has become a central thread in the broader longevity research conversation.
MOTS-c: a signaling peptide
MOTS-c is unusual among peptides because it is encoded by mitochondrial DNA rather than the cell’s nuclear genome. It is studied as a signaling molecule, meaning its research focus is on how it communicates the metabolic state of the mitochondria to the rest of the cell, particularly through activation of AMPK, a central regulator of cellular energy balance.
Read our full MOTS-c breakdown →
SS-31: a membrane-targeted peptide
SS-31 works through an entirely different mechanism. Rather than acting as a signaling molecule, it is engineered to physically concentrate on the inner mitochondrial membrane, where it binds to cardiolipin, a phospholipid involved in maintaining membrane structure. This is a direct, structural approach rather than a signaling one, and it is why SS-31 is studied separately for oxidative stress and membrane stability rather than metabolic signaling specifically.
Read our full SS-31 breakdown →
What actually connects them
MOTS-c and SS-31 are grouped together because they both target mitochondrial biology, not because they share a mechanism. Researchers studying age-related mitochondrial decline may be interested in both as complementary angles on the same underlying problem, one addressing cellular signaling and the other addressing membrane-level structural stability, rather than treating them as interchangeable options.
Frequently asked questions
Are MOTS-c and SS-31 interchangeable?
No. They act through different mechanisms, one as a signaling peptide and one as a membrane-stabilizing peptide, and are studied for different, though related, research questions.
Which mitochondrial peptide has more research behind it?
SS-31 has a longer research history, with studies dating back over a decade and progression into human clinical trials under the name elamipretide. MOTS-c research is comparatively newer, having been identified in 2015.
Look up a Certificate of Analysis →
For laboratory and research use only. Not for human consumption. This article is for informational purposes; it is not medical advice.
